Eupraxia Pharmaceuticals (EPRX) Return on Assets [ROA] (2024 - 2026)
Eupraxia Pharmaceuticals (EPRX) reported Return on Assets [ROA] of -38.19% for the quarter ended Jun 30, 2026, up 71.25 percentage points from -109.44% a year earlier and up 0.57 percentage points from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Return on Assets [ROA] (2024 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Eupraxia Pharmaceuticals posted Return on Assets [ROA] of -60.27%, up 38.26 percentage points from the prior year.
- By year, Return on Assets [ROA] came in at -98.53% in the year ended Dec 31, 2024 (+48.14 pp) and -146.67% in the year ended Dec 31, 2023.
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Return on Assets [ROA] in data going back to the quarter ended Mar 31, 2024.
- Year over year, Return on Assets [ROA] has now increased in each of the last four quarters, with an average year-over-year change of +52.32 percentage points over the last six quarters.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -38.75% (quarter ended Mar 31, 2026), -40.88% (quarter ended Dec 31, 2025) and -51.61% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | -38.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.19% |
| Mar 31, 2026 | -38.75% |
| Dec 31, 2025 | -40.88% |
| Sep 30, 2025 | -51.61% |
| Jun 30, 2025 | -109.44% |
| Mar 31, 2025 | -86.45% |
| Dec 31, 2024 | -120.06% |
| Sep 30, 2024 | -163.54% |
| Jun 30, 2024 | -90.36% |
| Mar 31, 2024 | -109.36% |
API Access
Eupraxia Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();